Dermata Therapeutics, Inc. - FORM S-1 - EX-99.1 - June 10, 2021

Attached files

file filename
S-1 - S-1 - Dermata Therapeutics, Inc.d137089ds1.htm
EX-99.4 - EX-99.4 - Dermata Therapeutics, Inc.d137089dex994.htm
EX-99.3 - EX-99.3 - Dermata Therapeutics, Inc.d137089dex993.htm
EX-99.2 - EX-99.2 - Dermata Therapeutics, Inc.d137089dex992.htm
EX-23.1 - EX-23.1 - Dermata Therapeutics, Inc.d137089dex231.htm
EX-10.13 - EX-10.13 - Dermata Therapeutics, Inc.d137089dex1013.htm
EX-10.12 - EX-10.12 - Dermata Therapeutics, Inc.d137089dex1012.htm
EX-10.7 - EX-10.7 - Dermata Therapeutics, Inc.d137089dex107.htm
EX-10.6 - EX-10.6 - Dermata Therapeutics, Inc.d137089dex106.htm
EX-10.5 - EX-10.5 - Dermata Therapeutics, Inc.d137089dex105.htm
EX-10.4 - EX-10.4 - Dermata Therapeutics, Inc.d137089dex104.htm
EX-10.3 - EX-10.3 - Dermata Therapeutics, Inc.d137089dex103.htm
EX-10.2 - EX-10.2 - Dermata Therapeutics, Inc.d137089dex102.htm
EX-10.1 - EX-10.1 - Dermata Therapeutics, Inc.d137089dex101.htm
EX-4.3 - EX-4.3 - Dermata Therapeutics, Inc.d137089dex43.htm
EX-4.1 - EX-4.1 - Dermata Therapeutics, Inc.d137089dex41.htm
EX-3.4 - EX-3.4 - Dermata Therapeutics, Inc.d137089dex34.htm
EX-3.3 - EX-3.3 - Dermata Therapeutics, Inc.d137089dex33.htm
EX-3.2 - EX-3.2 - Dermata Therapeutics, Inc.d137089dex32.htm
EX-3.1 - EX-3.1 - Dermata Therapeutics, Inc.d137089dex31.htm

Exhibit 99.1

CONSENT TO BE NAMED

I hereby confirm my consent to be named as a director of Dermata Therapeutics, Inc. (the “Company”), in the Registration Statement on Form S-1 filed by the Company with the Securities and Exchange Commission, including any and all amendments and post-effective amendments thereto and any amendments filed under Rule 462(b) (collectively, the “Registration Statement”). This consent may be filed as an exhibit to the Registration Statement.

 

DATED: ,April 26, 2021   

/s/ Mary Fisher

   Mary Fisher